Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.80 USD
Change Today +0.07 / 1.04%
Volume 131.8K
ADMP On Other Exchanges
As of 8:10 PM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David J. Marguglio

Senior Vice President of Corporate Development and Director, Adamis Pharmaceuticals Corporation
AgeTotal Calculated CompensationThis person is connected to 4 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. David J. Marguglio serves as a Senior Vice President of Corporate Development at Adamis Pharmaceuticals Corporation. Mr. Marguglio joined Adamis Pharmaceuticals Corporation as Vice President, Business Development and Investor Relations in April 2009 in connection with the closing of the merger transaction between Cellegy and Old Adamis. Mr. Marguglio was a co-founder of Old Adamis and served as its Vice President of Business Development and Investor Relations since ...

Read Full Background

Corporate Headquarters*

11682 El Camino Real
San Diego, California 92130

United States

Phone: 858-997-2400
Fax: --

Board Members Memberships*

Former Vice President of Business Development & Investor Relations and Director
Senior Vice President of Corporate Development and Director


Unknown/Other Education
Hankamer School of Business

Other Affiliations*

Annual Compensation*

Total Annual Compensation$287,672

Stock Options*

All Other Compensation$15,509
Exercisable Options47,150
Total Number of Options47,150

Total Compensation*

Total Annual Cash Compensation$303,181
Total Short Term Compensation$287,672
Other Long Term Compensation$15,509
Total Calculated Compensation$303,181
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADMP:US $6.80 USD +0.07


Jennifer K. Simpson Ph.D., M.S.N., C.R.N.P.Interim Chief Executive Officer, Interim President, Executive Vice President and Global Head of Business Operations
Delcath Systems, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADAMIS PHARMACEUTICALS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at